Project to focus on drug development for schizophrenia, depression

01/19/2010 | EurekAlert!

An international team of researchers, headed by H. Lundbeck A/S and King's College London, has formed the Novel Methods leading to New Medications in Depression and Schizophrenia, an academic-industry research tie-up that will focus on finding new ways to develop treatments for schizophrenia and depression. The project aims to develop new animal models for brain studies, as well as hardware and analysis methods that can be used in brain imaging, including MRI and PET.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC